Pharmocann Global (XTAE:PMCN-M) Accounts Payable & Accrued Expense : ₪5.76 Mil (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Pharmocann Global Accounts Payable & Accrued Expense?

Pharmocann Global's quarterly accounts payable & accrued expense declined from Dec. 2022 (₪7.30 Mil) to Jun. 2023 (₪6.05 Mil) and declined from Jun. 2023 (₪6.05 Mil) to Dec. 2023 (₪5.76 Mil).

Pharmocann Global's annual accounts payable & accrued expense increased from Dec. 2021 (₪5.63 Mil) to Dec. 2022 (₪7.30 Mil) but then declined from Dec. 2022 (₪7.30 Mil) to Dec. 2023 (₪5.76 Mil).

Pharmocann Global Accounts Payable & Accrued Expense Historical Data

The historical data trend for Pharmocann Global's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmocann Global Accounts Payable & Accrued Expense Chart

Pharmocann Global Annual Data

Trend

Dec09

Dec10

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3.73

4.33

5.63

7.30

5.76

Pharmocann Global Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															6.56	3.72	7.30	6.05	5.76

Pharmocann Global Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Pharmocann Global (XTAE:PMCN-M) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmocann Global Ltd (XTAE:PMCN-M) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ramat Yishai, PO Box 305, Kiryat Tivon, ISR, 3601201

Website

https://www.pharmocann.co.il

Pharmocann Global Ltd is an Israel-based company engaged in producing medical-related cannabis products which include oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various types of THC/CBD strains.

Pharmocann Global (XTAE:PMCN-M) Headlines

No Headlines